| Summary of Major Changes in the 2015 Red Book |
|
xxxiii | |
Section
1. Active And Passive Immunization |
|
|
|
|
1 | (2) |
|
Sources of Vaccine Information |
|
|
3 | (4) |
|
Discussing Vaccines With Patients and Parents |
|
|
7 | (6) |
|
Addressing Parents' Questions About Vaccine Safety and Effectiveness |
|
|
9 | (1) |
|
Common Misconceptions About Immunizations and the Institute of Medicine Findings |
|
|
10 | (2) |
|
Resources for Optimizing Communications With Parent About Immunizations |
|
|
12 | (1) |
|
Parental Refusal of Immunizations |
|
|
12 | (1) |
|
|
|
13 | (44) |
|
|
|
17 | (3) |
|
Vaccine Handling and Storage |
|
|
20 | (6) |
|
|
|
26 | (4) |
|
|
|
30 | (1) |
|
|
|
31 | (2) |
|
Minimum Ages and Minimum Intervals Between Vaccine Doses |
|
|
33 | (1) |
|
Interchangeability of Vaccine Products |
|
|
34 | (1) |
|
Simultaneous Administration of Multiple Vaccines |
|
|
35 | (1) |
|
|
|
36 | (1) |
|
|
|
37 | (1) |
|
Unknown or Uncertain Immunization Status |
|
|
38 | (1) |
|
|
|
38 | (18) |
|
Active Immunization of People Who Recently Received Immune Globulin and Other Blood Products |
|
|
38 | (2) |
|
Testing for Mycobacterium tuberculosis Infection |
|
|
40 | (1) |
|
Record Keeping and Immunization Information Systems |
|
|
40 | (2) |
|
|
|
42 | (1) |
|
|
|
43 | (1) |
|
|
|
43 | (1) |
|
Institute of Medicine Reviews of Adverse Events After Immunization |
|
|
44 | (2) |
|
Vaccine Adverse Event Reporting System (VAERS) |
|
|
46 | (3) |
|
Vaccine Safety Datalink Project |
|
|
49 | (1) |
|
Postlicensure Rapid Immunization Safety Monitoring (PRISM) |
|
|
49 | (1) |
|
Clinical Immunization Safety Assessment (LISA) Project |
|
|
50 | (1) |
|
Vaccine Injury Compensation |
|
|
51 | (1) |
|
Vaccine Contraindications and Precautions |
|
|
52 | (2) |
|
Hypersensitivity Reactions After Immunization |
|
|
54 | (1) |
|
Immediate-Type Allergic Reactions |
|
|
54 | (1) |
|
Delayed-Type Allergic Reactions |
|
|
55 | (1) |
|
|
|
56 | (1) |
|
Reporting of Vaccine-Preventable Diseases |
|
|
56 | (1) |
|
|
|
57 | (11) |
|
Immune Globulin Intramuscular (IGIM) |
|
|
58 | (1) |
|
Immune Globulin Intravenous (IGIV) |
|
|
59 | (5) |
|
Immune Globulin Subcutaneous (IGSC) |
|
|
64 | (1) |
|
Specific Immune Globulins |
|
|
64 | (1) |
|
Antibodies of Animal Origin (Animal Antisera) |
|
|
65 | (1) |
|
Treatment of Anaphylactic Reactions |
|
|
66 | (2) |
|
Immunization in Special Clinical Circumstances |
|
|
68 | (41) |
|
Immunization in Preterm and Low Birth Weight Infants |
|
|
68 | (2) |
|
Immunization in Pregnancy |
|
|
70 | (4) |
|
Immunization in Immunocompromised Children |
|
|
74 | (15) |
|
Immunization in Children With a Personal or Family History of Seizures |
|
|
89 | (1) |
|
Immunization in Children With Chronic Diseases |
|
|
89 | (1) |
|
Immunization in American Indian/Alaska Native Children |
|
|
90 | (3) |
|
Immunization in US Children Living Outside the United States |
|
|
93 | (1) |
|
Immunization in Adolescent and College Populations |
|
|
94 | (1) |
|
Immunization in Health Care Personnel |
|
|
95 | (3) |
|
Vaccination During Hospitalization, Including Anesthesia and Surgery |
|
|
98 | (1) |
|
Children Who Received Immunizations Outside the United States or Whose Immunization Status is Unknown or Uncertain |
|
|
98 | (3) |
|
|
|
101 | (8) |
Section
2. Recommendations For Care Of Children In Special Circumstances |
|
|
|
|
109 | (3) |
|
Blood Safety: Reducing the Risk of Transfusion-Transmitted Infections |
|
|
112 | (13) |
|
Blood Components and Plasma Derivatives |
|
|
112 | (1) |
|
Current Blood Safety Measures |
|
|
113 | (1) |
|
Transfusion-Transmitted Agents: Known Threats and Potential Pathogens |
|
|
113 | (9) |
|
|
|
122 | (3) |
|
|
|
125 | (7) |
|
Immunization of Mothers and Infants |
|
|
126 | (1) |
|
Transmission of Infectious Agents via Human Milk |
|
|
127 | (5) |
|
Antimicrobial Agents in Human Milk |
|
|
132 | (1) |
|
Children in Out-of-Home Child Care |
|
|
132 | (20) |
|
Classification of Care Service |
|
|
133 | (1) |
|
Management and Prevention of Illness |
|
|
134 | (2) |
|
Recommendations for Inclusion or Exclusion |
|
|
136 | (1) |
|
Infectious Diseases-Epidemiology and Control |
|
|
137 | (11) |
|
|
|
148 | (4) |
|
|
|
152 | (9) |
|
Diseases Preventable by Routine Childhood Immunization |
|
|
153 | (2) |
|
Infections Spread by the Respiratory Route |
|
|
155 | (1) |
|
Infections Spread by Direct Contact |
|
|
156 | (1) |
|
Infections Spread by the Fecal-Oral Route |
|
|
157 | (1) |
|
Infections Spread by Blood and Body Fluids |
|
|
158 | (3) |
|
Infection Control and Prevention for Hospitalized Children |
|
|
161 | (14) |
|
|
|
161 | (9) |
|
Strategies to Prevent Health Care-Associated Infections |
|
|
170 | (1) |
|
|
|
171 | (2) |
|
|
|
173 | (1) |
|
|
|
173 | (1) |
|
|
|
174 | (1) |
|
Infection Control and Prevention in Ambulatory Settings |
|
|
175 | (2) |
|
Sexually Transmitted Infections in Adolescents and Children |
|
|
177 | (12) |
|
|
|
177 | (5) |
|
Diagnosis and Treatment of STIs in Children |
|
|
182 | (1) |
|
Social Implications of STIs in Children |
|
|
183 | (2) |
|
Sexual Victimization and STIs |
|
|
185 | (4) |
|
Hepatitis and Youth in Correctional Settings |
|
|
189 | (5) |
|
|
|
190 | (1) |
|
|
|
191 | (1) |
|
|
|
192 | (2) |
|
Medical Evaluation for Infectious Diseases for Internationally Adopted, Refugee, and Immigrant Children |
|
|
194 | (7) |
|
Consideration of Certain Pathogens and Conditions |
|
|
196 | (5) |
|
|
|
196 | (1) |
|
|
|
196 | (1) |
|
|
|
197 | (1) |
|
|
|
197 | (1) |
|
|
|
198 | (1) |
|
|
|
198 | (1) |
|
|
|
199 | (1) |
|
Chagas Disease (American Trypanosomiasis) |
|
|
200 | (1) |
|
|
|
200 | (1) |
|
Other Infectious Diseases |
|
|
201 | (1) |
|
Injuries From Discarded Needles in the Community |
|
|
201 | (4) |
|
Wound Care and Tetanus Prophylaxis |
|
|
202 | (1) |
|
|
|
202 | (2) |
|
Preventing Needlestick Injuries |
|
|
204 | (1) |
|
|
|
205 | (5) |
|
Prevention of Tickborne Infections |
|
|
210 | (3) |
|
Prevention of Mosquitoborne Infections |
|
|
213 | (3) |
|
Prevention of Illnesses Associated with Recreational Water Use |
|
|
216 | (3) |
|
Diseases Transmitted by Animals (Zoonoses) |
|
|
219 | (6) |
Section
3. Summaries Of Infectious Diseases |
|
|
|
|
225 | (1) |
|
|
|
226 | (2) |
|
|
|
228 | (3) |
|
Amebic Meningoencephalitis and Keratitis |
|
|
231 | (3) |
|
|
|
234 | (6) |
|
|
|
240 | (6) |
|
Arcanobacterium haemoOticum Infections |
|
|
246 | (1) |
|
Ascaris lumbricoides Infections |
|
|
247 | (2) |
|
|
|
249 | (3) |
|
|
|
252 | (1) |
|
|
|
253 | (2) |
|
Bacillus cereus Infections |
|
|
255 | (1) |
|
|
|
256 | (2) |
|
Bacteroides and Prevotella Infections |
|
|
258 | (2) |
|
Balantidium coli Infections (Balantidiasis) |
|
|
260 | (1) |
|
|
|
260 | (2) |
|
Infections With Blastogstis hominis and Other Subtypes |
|
|
262 | (1) |
|
|
|
263 | (1) |
|
|
|
264 | (1) |
|
Borrelia Infections (Relapsing Fever) |
|
|
265 | (3) |
|
|
|
268 | (2) |
|
|
|
270 | (3) |
|
|
|
273 | (2) |
|
|
|
275 | (5) |
|
Cat-Scratch Disease (Bartonella henselae) |
|
|
280 | (3) |
|
|
|
283 | (1) |
|
|
|
284 | (10) |
|
Chlamydophila (formerly Chlamydia) pneumoniae |
|
|
284 | (2) |
|
Chlamydophila (formerly Chlamydia) psittaci (Psittacosis, Ornithosis, Parrot Fever) |
|
|
286 | (2) |
|
|
|
288 | (6) |
|
|
|
294 | (8) |
|
Botulism and Infant Botulism (Clostridium botulinum) |
|
|
294 | (3) |
|
Clostridial Myonecrosis (Gas Gangrene) |
|
|
297 | (1) |
|
|
|
298 | (3) |
|
Clostridium perfringens Food Poisoning |
|
|
301 | (1) |
|
|
|
302 | (4) |
|
Coronaviruses, Including SARS and MERS |
|
|
306 | (3) |
|
Cryptococcus neoformans and Cryptococcus gattii Infections (Cryptococcosis) |
|
|
309 | (3) |
|
|
|
312 | (3) |
|
|
|
315 | (1) |
|
|
|
316 | (1) |
|
Cytomegalovirus Infection |
|
|
317 | (5) |
|
|
|
322 | (3) |
|
|
|
325 | (4) |
|
Ehrlichia, Anaplasma, and Related Infections (Human Ehrlichiosis, Anaplasmosis, and Related Infections) |
|
|
329 | (4) |
|
Enterovirus (Nonpoliovirus) (Group A and B Coxsackieviruses, Echoviruses, Numbered Enteroviruses) |
|
|
333 | (3) |
|
Epstein-Barr Virus Infections (Infectious Mononucleosis) |
|
|
336 | (4) |
|
Escherichia coli and Other Gram-Negative Bacilli (Septicemia and Meningitis in Neonates) |
|
|
340 | (3) |
|
Escherichia coli Diarrhea (Including Hemolytic-Uremic Syndrome) |
|
|
343 | (5) |
|
|
|
348 | (3) |
|
Fusobacterium Infections (Including Lemierre Disease) |
|
|
351 | (2) |
|
Giardia intestinalis (formerly Giardia lamblia and Giardia duodenalis) Infections (Giardiasis) |
|
|
353 | (3) |
|
|
|
356 | (11) |
|
Granuloma Inguinale (Donovanosis) |
|
|
367 | (1) |
|
Haemophilus influenzae Infections |
|
|
368 | (8) |
|
Hantavirus Pulmonary Syndrome |
|
|
376 | (3) |
|
Helicobacter pylori Infections |
|
|
379 | (2) |
|
Hemorrhagic Fevers Caused by Arenaviruses |
|
|
381 | (2) |
|
Hemorrhagic Fevers Caused by Bunyaviruses |
|
|
383 | (3) |
|
Hemorrhagic Fevers Caused by Filoviruses: Ebola and Marburg |
|
|
386 | (5) |
|
|
|
391 | (9) |
|
|
|
400 | (23) |
|
|
|
423 | (7) |
|
|
|
430 | (1) |
|
|
|
431 | (1) |
|
|
|
432 | (13) |
|
|
|
445 | (3) |
|
Hookworm Infections (Ancylostoma duodenale and Necator americanus) |
|
|
448 | (1) |
|
Human Herpesvirus 6 (Including Roseola) and 7 |
|
|
449 | (3) |
|
|
|
452 | (1) |
|
Human Immunodeficiency Virus Infection |
|
|
453 | (23) |
|
|
|
476 | (17) |
|
Isosporiasis (now designated as Cystoisosporiasis) |
|
|
493 | (1) |
|
|
|
494 | (6) |
|
Kingella kingae Infections |
|
|
500 | (1) |
|
Legionella pneumophila Infections |
|
|
501 | (2) |
|
|
|
503 | (3) |
|
|
|
506 | (4) |
|
|
|
510 | (3) |
|
Listeria monogtogenes Infections (Listeriosis) |
|
|
513 | (3) |
|
Lyme Disease (Lyme Borreliosis, Borrelia burgdoeri Infection) |
|
|
516 | (9) |
|
Lymphatic Filariasis (Bancroftian, Malayan, and Timorian) |
|
|
525 | (2) |
|
Lymphocytic Choriomeningitis |
|
|
527 | (1) |
|
|
|
528 | (7) |
|
|
|
535 | (12) |
|
|
|
547 | (11) |
|
|
|
558 | (2) |
|
Microsporidia Infections (Microsporidiosis) |
|
|
560 | (1) |
|
|
|
561 | (2) |
|
Moraxella catarrhalis Infections |
|
|
563 | (1) |
|
|
|
564 | (4) |
|
Mycoplasma pneumoniae and Other Mycoplasma Species Infections |
|
|
568 | (3) |
|
|
|
571 | (2) |
|
Norovirus and Other Human Calicivirus Infections |
|
|
573 | (2) |
|
Onchocerciasis (River Blindness, Filariasis) |
|
|
575 | (1) |
|
|
|
576 | (7) |
|
Paracoccidioidomycosis (South American Blastomycosis) |
|
|
583 | (1) |
|
|
|
584 | (2) |
|
Parainfluenza Viral Infections |
|
|
586 | (2) |
|
|
|
588 | (4) |
|
Human Parechovirus Infections |
|
|
592 | (1) |
|
Parvovirus B19 (Erythema Infectiosum, Fifth Disease) |
|
|
593 | (3) |
|
|
|
596 | (1) |
|
Pediculosis Capitis (Head Lice) |
|
|
597 | (4) |
|
Pediculosis Corporis (Body Lice) |
|
|
601 | (1) |
|
Pediculosis Pubis (Pubic Lice, Crab Lice) |
|
|
602 | (1) |
|
Pelvic Inflammatory Disease |
|
|
603 | (5) |
|
Pertussis (Whooping Cough) |
|
|
608 | (13) |
|
Pinworm Infection (Enterobius vermicularis) |
|
|
621 | (1) |
|
Pityriasis Versicolor (Tinea Versicolor) |
|
|
622 | (2) |
|
|
|
624 | (2) |
|
|
|
626 | (12) |
|
Pneumogstisfirovecii Infections |
|
|
638 | (6) |
|
|
|
644 | (6) |
|
Polyomaviruses (BK Virus and JC Virus) |
|
|
650 | (3) |
|
Prion Diseases: Transmissible Spongiform Encephalopathies |
|
|
653 | (3) |
|
QFever (Coxiella burnetii Infection) |
|
|
656 | (2) |
|
|
|
658 | (8) |
|
|
|
666 | (1) |
|
Respiratory Syncytial Virus |
|
|
667 | (9) |
|
|
|
676 | (1) |
|
|
|
677 | (3) |
|
|
|
680 | (2) |
|
Rocky Mountain Spotted Fever |
|
|
682 | (2) |
|
|
|
684 | (4) |
|
|
|
688 | (7) |
|
|
|
695 | (7) |
|
|
|
702 | (2) |
|
|
|
704 | (2) |
|
|
|
706 | (3) |
|
|
|
709 | (3) |
|
|
|
712 | (2) |
|
Staphylococcal Food Poisoning |
|
|
714 | (1) |
|
Staphylococcal Infections |
|
|
715 | (17) |
|
Group A Streptococcal Infections |
|
|
732 | (13) |
|
Group B Streptococcal Infections |
|
|
745 | (5) |
|
Non-Group A or B Streptococcal and Enterococcal Infections |
|
|
750 | (4) |
|
Strongyloidiasis (Strongyloides stercoralis) |
|
|
754 | (1) |
|
|
|
755 | (13) |
|
Tapeworm Diseases (Taeniasis and Cysticercosis) |
|
|
768 | (3) |
|
Other Tapeworm Infections (Including Hydatid Disease) |
|
|
771 | (2) |
|
|
|
773 | (5) |
|
Tinea Capitis (Ringworm of the Scalp) |
|
|
778 | (3) |
|
Tinea Corporis (Ringworm of the Body) |
|
|
781 | (2) |
|
|
|
783 | (1) |
|
Tinea Pedis and Tinea Unguium (Athlete's Foot, Ringworm of the Feet) |
|
|
784 | (2) |
|
Toxocariasis (Visceral Toxocariasis [ previously Visceral Larva Migrans], Ocular Toxocariasis [ previously Ocular Larva Migrans]) |
|
|
786 | (1) |
|
Toxoplasma gondii Infections (Toxoplasmosis) |
|
|
787 | (9) |
|
Trichinellosis (Trichinella spiralis and Other Species) |
|
|
796 | (2) |
|
Trichomonas vaginalis Infections (Trichomoniasis) |
|
|
798 | (2) |
|
Trichuriasis (Whipworm Infection) |
|
|
800 | (1) |
|
African Trypanosomiasis (African Sleeping Sickness) |
|
|
801 | (2) |
|
American Trypanosomiasis (Chagas Disease) |
|
|
803 | (1) |
|
|
|
804 | (27) |
|
Diseases Caused by Nontuberculous Mycobacteria (Environmental Mycobacteria, Mycobacteria Other Than Mycobacterium tuberculosis) |
|
|
831 | (8) |
|
|
|
839 | (2) |
|
Endemic Typhus (Murine Typhus) |
|
|
841 | (2) |
|
Epidemic Typhus (Louseborne or Sylvatic Typhus) |
|
|
843 | (2) |
|
Ureaplasma urealyticum and Ureaplasma parvum Infections |
|
|
845 | (1) |
|
Varicella-Zoster Infections |
|
|
846 | (14) |
|
|
|
860 | (5) |
|
Cholera (Vibrio cholerae) |
|
|
860 | (3) |
|
|
|
863 | (2) |
|
|
|
865 | (3) |
|
Yersinia enterocolitica and Tersinia pseudotuberculosis Infections (Enteritis and Other Illnesses) |
|
|
868 | (3) |
Section
4. Antimicrobial Agents And Related Therapy |
|
|
|
|
871 | (3) |
|
|
|
872 | (1) |
|
|
|
873 | (1) |
|
|
|
873 | (1) |
|
Antimicrobial Resistance and Antimicrobial Stewardship: Appropriate and Judicious Use of Antimicrobial Agents |
|
|
874 | (6) |
|
|
|
874 | (1) |
|
Factors Contributing to Resistance |
|
|
874 | (1) |
|
Antimicrobial Resistance Threats |
|
|
875 | (1) |
|
Actions to Prevent or Slow Antimicrobial Resistance |
|
|
876 | (1) |
|
Antimicrobial Stewardship |
|
|
876 | (1) |
|
|
|
877 | (1) |
|
Principles of Appropriate Use of Antimicrobial Therapy for Upper Respiratory Tract Infections |
|
|
878 | (2) |
|
|
|
880 | (1) |
|
Tables of Antibacterial Drug Dosages |
|
|
881 | (15) |
|
Sexually Transmitted Infections |
|
|
896 | (9) |
|
Antifungal Drugs for Systemic Fungal Infections |
|
|
905 | (4) |
|
|
|
905 | (1) |
|
|
|
906 | (1) |
|
|
|
906 | (2) |
|
|
|
908 | (1) |
|
Recommended Doses of Parenteral and Oral Antifungal Drugs |
|
|
909 | (4) |
|
Topical Drugs for Superficial Fungal Infections |
|
|
913 | (6) |
|
|
|
919 | (8) |
|
Drugs for Parasitic Infections |
|
|
927 | (30) |
|
MedWatch The FDA Safety Information and Adverse Event-Reporting Program |
|
|
957 | (2) |
Section
5. Antimicrobial Prophylaxis |
|
|
Antimicrobial Prophylaxis |
|
|
959 | (2) |
|
Infection-Prone Body Sites |
|
|
960 | (1) |
|
Exposure to Specific Pathogens |
|
|
961 | (1) |
|
|
|
961 | (1) |
|
Antimicrobial Prophylaxis in Pediatric Surgical Patients |
|
|
961 | (9) |
|
Guidelines for Appropriate Use |
|
|
962 | (1) |
|
Indications for Prophylaxis |
|
|
962 | (2) |
|
Surgical Site Infection Criteria |
|
|
964 | (1) |
|
Timing of Administration of Prophylactic Antimicrobial Agents |
|
|
964 | (1) |
|
Dosing and Duration of Administration of Antimicrobial Agents |
|
|
965 | (1) |
|
Preoperative Screening and Decolonization |
|
|
965 | (1) |
|
Recommended Antimicrobial Agents |
|
|
965 | (5) |
|
Prevention of Bacterial Endocarditis |
|
|
970 | (2) |
|
Prevention of Neonatal Ophthalmia |
|
|
972 | (3) |
|
|
|
972 | (1) |
|
|
|
973 | (1) |
|
Nongonococcal, Nonchlamydial Ophthalmia |
|
|
974 | (1) |
|
Administration of Neonatal Ophthalmic Prophylaxis |
|
|
974 | |
| Appendices |
|
|
|
|
975 | (5) |
|
II Codes for Commonly Administered Pediatric Vaccines/Toxoids and Immune Globulins |
|
|
980 | (7) |
|
III National Childhood Vaccine Injury Act Reporting and Compensation Tables |
|
|
987 | (5) |
|
IV Nationally Notifiable Infectious Diseases in the United States |
|
|
992 | (2) |
|
V Guide to Contraindications and Precautions to Immunizations |
|
|
994 | (10) |
|
VI Prevention of Disease From Contaminated Food Products |
|
|
1004 | (4) |
|
VII Clinical Syndromes Associated With Foodborne Diseases |
|
|
1008 | (6) |
|
VIII Diseases Transmitted by Animals (Zoonoses) |
|
|
1014 | |
